Inhibition of osteolytic bone metastasis by unfractionated heparin
- PMID: 18814041
- DOI: 10.1007/s10585-008-9212-0
Inhibition of osteolytic bone metastasis by unfractionated heparin
Abstract
In the current study, we examine heparin's anti-metastatic properties by using a well-defined mouse model of osteolytic bone metastasis. C57BL/6 mice were treated with increasing doses of unfractionated heparin (15, 20, or 25 units/mouse) 30 min prior to the left ventricular injection of GFP-transfected B16F10 melanoma cells. Heparin's effect on tumour burden and bone strength was then quantified 14 days later by bone histomorphometry and biomechanical testing, respectively. Based on histomorphometric analysis of the femurs, injection of GFP-transfected melanoma cells resulted in a 37% decrease in cancellous bone volume and a 68% increase in osteoclast surface. This was associated with a 13% reduction in bone strength as measured by biomechanical testing. However, when the mice were first pre-treated with 25 units of heparin, tumour burden was decreased by 73% and tumour cell-dependent decreases in both cancellous bone volume and bone strength were prevented. Based on these observations, we conclude that heparin inhibits the ability of tumour cells to metastasize to bone and that as such, prevents tumour cell-induced decreases in bone strength.
Similar articles
-
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.J Natl Cancer Inst. 2007 Feb 21;99(4):322-30. doi: 10.1093/jnci/djk054. J Natl Cancer Inst. 2007. PMID: 17312309
-
RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases.J Thorac Oncol. 2014 Mar;9(3):345-54. doi: 10.1097/JTO.0000000000000070. J Thorac Oncol. 2014. PMID: 24496001
-
Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.Clin Cancer Res. 2009 Jun 1;15(11):3751-9. doi: 10.1158/1078-0432.CCR-08-3123. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470728
-
The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.Thromb Res. 2014 May;133(5):855-62. doi: 10.1016/j.thromres.2014.02.020. Epub 2014 Feb 26. Thromb Res. 2014. PMID: 24636486
-
Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells.FEBS Lett. 2007 Feb 6;581(3):565-71. doi: 10.1016/j.febslet.2007.01.005. Epub 2007 Jan 16. FEBS Lett. 2007. PMID: 17254571
Cited by
-
Exosomes impact survival to radiation exposure in cell line models of nervous system cancer.Oncotarget. 2018 Nov 16;9(90):36083-36101. doi: 10.18632/oncotarget.26300. eCollection 2018 Nov 16. Oncotarget. 2018. PMID: 30546829 Free PMC article.
-
Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis.Front Oral Health. 2024 Nov 6;5:1495942. doi: 10.3389/froh.2024.1495942. eCollection 2024. Front Oral Health. 2024. PMID: 39568788 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical